Our results reveal that the miR-22/Sp1/PTEN/AKT axis might elucidate the complex molecular mechanisms which regulate progression and metastasis in CRC, and represents a novel strategy for prognostic prediction and the treatment of patients with CRC. This evidence concerns the gene AKT1 and colorectal carcinoma.